| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 08/07/2003 | US20030149270 Processes for the preparation of 3-aminocarboxylic acids and their esters |
| 08/07/2003 | US20030149250 Labeled compounds useful in imaging amyloid deposits and useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 08/07/2003 | US20030149052 Side effect reduction |
| 08/07/2003 | US20030149015 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
| 08/06/2003 | EP1333023A1 Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites |
| 08/06/2003 | EP1332132A2 Enamine derivatives as cell adhesion molecules |
| 08/06/2003 | CN1434039A Process for preparing 1,3-dibenzyl imidazoline-2-ketone-cis-4, 5-dicarboxylic acid (Ôàá) |
| 08/06/2003 | CN1434025A Process for preparing 3-hydroxy-3-methylbutyrate (HMB) amino acid salt |
| 08/06/2003 | CN1117069C Process for preparation of inorganic salt of optical phenylglycine derivative |
| 08/06/2003 | CN1117068C Method for preparation of laminine |
| 08/05/2003 | US6602817 Combination approach to chiral reagents or catalysts having amine or amino alcohol ligands |
| 07/31/2003 | WO2003062253A1 Metal complexes for use in metathesis |
| 07/31/2003 | WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/31/2003 | WO2003062191A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/31/2003 | WO2003062185A1 Methods for producing substituted acrylic acid esters and use of the latter for producing substituted $g(g)-amino acids |
| 07/31/2003 | WO2003061698A1 6-fluorobicyclo[3.1.0]hexane derivatives |
| 07/31/2003 | WO2003061595A2 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | WO2002034211A3 Antiperspirant salts for enhanced cosmetic products |
| 07/31/2003 | WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai |
| 07/31/2003 | US20030144531 Preparing chirally pure S-enantiomers of alpha -amino acids comprising the steps of: a) preparing an organometallic reagent from an alkyl halide of the formula (R) 2CH(CH2)nCH2X; b) adding the organometallic reagent to carbon dioxide to form |
| 07/31/2003 | CA2474259A1 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | CA2473545A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/31/2003 | CA2473029A1 Ruthenium and osmium carbene complexes for use in metathesis |
| 07/30/2003 | EP1330464A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 07/30/2003 | EP1330428A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
| 07/30/2003 | EP0783482B1 Cationic transport reagents |
| 07/30/2003 | CN1433397A Method for the prepararation of enantiomerically enriched compounds |
| 07/30/2003 | CN1433396A Pharmaceutical compounds |
| 07/30/2003 | CN1433274A Sweeteners pariticularly for coffee and tea |
| 07/30/2003 | CN1116285C Bis (acridinecarboxamide) and Bis (phenazinecarboxamide) as antitumour agents |
| 07/30/2003 | CN1116273C Nitrosation method of phenolic composition sustituted by electro-attracting group and use thereof |
| 07/29/2003 | US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting |
| 07/29/2003 | US6600031 Methods of making nucleic acid or oligonucleotide arrays |
| 07/29/2003 | US6599940 Neurotransmitters |
| 07/24/2003 | WO2003059922A1 Concentrated aqueous iron chelate composition |
| 07/24/2003 | WO2003059917A1 Synthetic hydrotalcites, syntheses and uses |
| 07/24/2003 | WO2003059915A2 ENANTIOSELECTIVE METHODS FOR PREPARING α- AND β-AMINO ACID DERIVATIVES |
| 07/24/2003 | WO2003059865A1 Processes for the preparation of glutamic acid compounds and intermediates thereof and novel intermediates used in the processes |
| 07/24/2003 | WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 07/24/2003 | WO2003041646A3 L-dopa ethyl ester salts and uses thereof |
| 07/24/2003 | US20030139418 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 07/24/2003 | US20030139376 Lipoxin A4 analogs |
| 07/24/2003 | US20030138745 Fluorine compound, surfactant, aqueous coating composition and silver halide photographic light-sensitive material using them |
| 07/24/2003 | CA2473893A1 Stable salts of o-acetylsalicylic acid with basic amino acids ii |
| 07/24/2003 | CA2471032A1 Synthetic hydrotalcites, syntheses and uses |
| 07/23/2003 | EP1328664A1 A multistep process for recovering betaine, erythritol, inositol, sucrose, mannitol, glycerol and amino acids from a process solution using a weakly acid cation exchange resin |
| 07/23/2003 | EP1328508A2 Propionic acid derivatives with ppar-alpha activating properties |
| 07/23/2003 | EP1328506A2 Novel intermediates for use in retinoid synthesis |
| 07/23/2003 | EP1328505A1 Dimethylamine/ester adducts and their use in polymerizable compositions |
| 07/23/2003 | EP1224162B1 Mixed-metal chelates and proces for the preparation thereof |
| 07/23/2003 | EP0898559B1 Cytoprotective compounds |
| 07/23/2003 | EP0888278B1 Antidiabetic agents |
| 07/23/2003 | EP0628044B1 Therapeutic nucleosides |
| 07/23/2003 | CN1431197A Alanine class compound, its preparing method and use |
| 07/23/2003 | CN1431193A Method for producing complexation metal salt of ethylenediamine tetra acetic acid |
| 07/23/2003 | CN1115145C Improving tolerability of pharmaceutically active beta-amino acids |
| 07/22/2003 | US6596900 Brain, nervous system, neurodegenerative, gastrointestinal, sleep, rheumatic, and psychological disorders; analgesics, antiepileptic agents |
| 07/22/2003 | US6596878 Protein kinase inhibitor compositio; used to treat cell proliferative disorders such as cancers charcterized by over-activity or inappropriate activity HER2 or EGFR. |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/17/2003 | WO2003057717A2 Crystallization of amino acids using ultrasonic agitation |
| 07/17/2003 | WO2003057661A1 Prodrugs of excitatory amino acids |
| 07/17/2003 | WO2003033097A3 Rotor-stator apparatus and process for the formation of particles |
| 07/17/2003 | US20030135065 Process for the production of L-DOPA ethyl ester |
| 07/17/2003 | US20030134902 Novel dicarboxylic acid derivatives |
| 07/17/2003 | US20030133953 Complexing a biologically active agent with a perturbant to reversibly transform and exposing a membrane or bilayer to the supramolecular complex |
| 07/17/2003 | US20030131784 Process for the crystallization of non-sucrose substances |
| 07/17/2003 | CA2472690A1 Crystallization of amino acids using ultrasonic agitation |
| 07/16/2003 | EP1326826A1 Use of amino acids for treating pain |
| 07/16/2003 | EP1132375B1 Aminoacrylic acid derivatives and process for producing the same |
| 07/16/2003 | CN1429812A Glutamic acid extraction method |
| 07/15/2003 | US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes |
| 07/15/2003 | US6593489 Catalytic stereoselective hydrogenation |
| 07/15/2003 | US6593478 Preparing carnitine |
| 07/15/2003 | CA2238465C Triaromatic compounds, compositions containing them and uses |
| 07/10/2003 | WO2003055846A1 Diaminodicarboxylic acids and intermediates thereof |
| 07/10/2003 | US20030130539 Treating carnitine chloride with an ion exchanger to form an inner salt in aqueous solution before reacting with mucic acid |
| 07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030130165 Method for treating neurodegenerative disorders |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | EP1325012A2 A composition and method for preparing amino acid chelates free of interfering ions |
| 07/09/2003 | EP1324979A2 Ionic liquids and their use as solvents |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | EP1165496B1 Substituted aniline compounds |
| 07/09/2003 | EP1098871B1 alpha-AMINO ACID PHENYL ESTER DERIVATIVES |
| 07/09/2003 | EP0840773B1 Aromatic esters of polyalkylphenoxyalkanols and fuel compositions containing the same |
| 07/09/2003 | CN1429197A Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 07/09/2003 | CN1429196A Process for preparation of aniline compounds |
| 07/09/2003 | CN1113695C Catalyst for dehydrogenation of amino alcohols to amino carboxylic acid or of ethylene glycol (derivatives) to oxycarboxylic acids, method for their production and their use |
| 07/08/2003 | US6590115 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds |
| 07/03/2003 | WO2003053974A1 Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 07/03/2003 | WO2003053911A1 Acetyl l-carnitine salt with a dicarboxilic organic acid and process for preparing same |
| 07/03/2003 | WO2003053910A1 Stable isotope-labeled amino acid, method of integrating the same into target protein, method of nmr structural analysis of protein and process for producing site-selective stable isotope-labeled fumaric acid and tartaric acid |
| 07/03/2003 | WO2003053909A1 Process for preparing amino acid tert-butyl ester hydrochloric acid salts |
| 07/03/2003 | US20030125510 Comomer compositions for production of imide-containing polyamino acids |
| 07/03/2003 | US20030125329 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125328 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125315 Providing a focused approach that permits a more rapid screening of probes with potential for association with a particular binding site with a higher likelihood of success; combinatorial chemistry; screening; computer software |
| 07/03/2003 | US20030125200 Raney copper which is doped with at least one metal from the group comprising iron and/or noble metals is used as a catalyst in the dehydrogenation of alcohols. |
| 07/03/2003 | US20030124673 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |